Search Results - "Seddiq, Marjilla"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Severe macrothrombocytopenia with platelet CD9 deficiency responsive to romiplostim

    Severe macrothrombocytopenia with platelet CD9 deficiency responsive to romiplostim by Seddiq, Marjilla, Gadgeel, Manisha, Persaud, Yogindra, Lafferty, Jennifer, Savaşan, Süreyya

    Published in British journal of haematology (01-08-2020)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation

    Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation by Persaud, Yogindra, Seddiq, Marjilla, Wu, Yi‐Mi, Robinson, Dan R., Poulik, Janet, Altinok, Deniz, Roarty, John D., Mody, Rajen, Taub, Jeffrey W.

    Published in Pediatric blood & cancer (01-08-2021)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    A Case Report of Intracardiac Hodgkin Lymphoma in an Adolescent Female

    A Case Report of Intracardiac Hodgkin Lymphoma in an Adolescent Female by Seddiq, Marjilla, Zaidi, Ahmar U., Powell, William, Henry, Meret

    Published in Journal of pediatric hematology/oncology (26-01-2022)
    “…Primary cardiac tumors are quite rare in children, and only a small portion are malignant. Presenting symptoms may be nonspecific, often mimicking those of…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    A Case Report of Intracardiac Hodgkin Lymphoma in an Adolescent Female

    A Case Report of Intracardiac Hodgkin Lymphoma in an Adolescent Female by Seddiq, Marjilla, Zaidi, Ahmar U., Powell, William, Henry, Meret

    Published in Journal of pediatric hematology/oncology (01-04-2022)
    “…Primary cardiac tumors are quite rare in children, and only a small portion are malignant. Presenting symptoms may be nonspecific, often mimicking those of…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development

    Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development by Donaldson, Joshua M, Seddiq, Marjilla, Fusco, Michael J, Singla, Shyamli, Pamuk, Gulsum E, Lee-Alonso, Rosa J, Mixter, Bronwyn D, Goldberg, Kirsten B, Amiri-Kordestani, Laleh, de Claro, R Angelo, Drezner, Nicole, Gormley, Nicole J, Kanapuru, Bindu, Lemery, Steven J, Fashoyin-Aje, Lola A, Richardson, Nicholas C, Singh, Harpreet, Suzman, Daniel L, Theoret, Marc R, Kluetz, Paul G, Pazdur, Richard

    Published in Cancer discovery (12-12-2023)
    “…Cancer drug development remained robust in 2023. Highlights of U.S. drug approvals this year include new immunotherapies and targeted drug development in adult…”
    Get more information
    Journal Article
    Save to List
    Saved in:
  6. 6
    Severe macrothrombocytopenia with platelet CD9 deficiency responsive to romiplostim

    Severe macrothrombocytopenia with platelet CD9 deficiency responsive to romiplostim by Seddiq, Marjilla, Gadgeel, Manisha, Persaud, Yogindra, Lafferty, Jennifer, Savaşan, Süreyya

    Published in British journal of haematology (01-08-2020)
    Get full text
    Report
    Save to List
    Saved in:
  7. 7
    Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation

    Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation by Persaud, Yogindra, Seddiq, Marjilla, Wu, Yi-Mi, Robinson, Dan R, Poulik, Janet, Altinok, Deniz, Roarty, John D, Mody, Rajen, Taub, Jeffrey W

    Published in Pediatric blood & cancer (01-08-2021)
    Get full text
    Report
    Save to List
    Saved in:

Search Tools: